According to an IBEF report, the Indian pharma market is poised to reach USD 130 billion by 2030, reinforcing the long-term need for engineering and design consulting. The pharmaceutical sector in India is in a cusp of major disruption with advancements in technologies, revamped manufacturing and R&D capabilities and stringent regulatory standards.
Known as the World’s Pharma Hub, the country is set to spearhead the innovation going forward. It is known to us that India has been a significant global contributor to the supply of quality medicines. As... >>More
Amit Mookim, CEO, Immuneel Therapeutics
Sandeep Raktate, President - Operations (India & Ireland), Amneal Pharmaceuticals
Ankit Gupta, President, ASPA
Aditya Sharma, Head - Process Solutions (India Region), Merck Life Science